Desmond A Schatz, MD - Research

Research at a glance

Top areas of exploration

Diabetes Mellitus, Type 1 , 253 publications
Autoantibodies , 92 publications
Insulin , 68 publications
Islets of Langerhans , 49 publications

Research activity

381 publications

23,284 citations

Why is this important?

Active clinical trials

ITN095AI DESIGNATE

This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0. Participants will be randomized 1:1:1:1 to one of four possible鈥�

Investigator: Desmond A Schatz
Status: Accepting Candidates
Ages: 8 Years - 45 Years
Sexes: All

My publications

381 publications

2019

Enhanced Understanding of the Natural History of Pre-Type 1 Diabetes: Fundamental to Prevention.

Pediatric endocrinology reviews : PER

鈥�

2019

Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome.

Nature communications

鈥�

2019

Immune Intervention in Type 1 Diabetes.

Diabetes technology & therapeutics

鈥�

2019

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.

JCI insight

鈥�

2019

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Diabetes care

鈥�

BOB体育

Desmond A Schatz, MD : Research

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Enhanced Understanding of the Natural History of Pre-Type 1 Diabetes: Fundamental to Prevention.

Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome.

Immune Intervention in Type 1 Diabetes.

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

BOB体育

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Enhanced Understanding of the Natural History of Pre-Type 1 Diabetes: Fundamental to Prevention.

Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome.

Immune Intervention in Type 1 Diabetes.

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.